Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfhydryl-containing enzymes are a diverse group of proteins that utilize the nucleophilic properties of the cysteine thiol (-SH) group for catalysis, regulation, or structural integrity. This broad category includes critical therapeutic targets such as cysteine proteases (e.g., cathepsins and caspases), which are involved in protein degradation and apoptosis, and metabolic enzymes like aldehyde dehydrogenase (ALDH) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [1][2]. The reactivity of the sulfhydryl group makes these enzymes susceptible to modulation by various pharmacological agents, including covalent inhibitors and redox-active compounds. For instance, the drug disulfiram exerts its effects by covalently modifying the active-site thiol of ALDH, while arsenic trioxide targets the thiol-rich active sites of thioredoxin reductase to induce apoptosis in cancer cells [3][4]. Historically, these enzymes have also been recognized as the primary targets of heavy metal toxicity, where ions like mercury and lead bind to essential thiols, disrupting cellular metabolism [5]. While targeting specific sulfhydryl-containing enzymes offers significant therapeutic potential in oncology and inflammatory diseases, the ubiquity of cysteine residues across the proteome presents challenges for achieving high selectivity and minimizing off-target toxicity [6]. Sources: [1] Turk, V., et al. (2012). "Cysteine cathepsins: from structure to function and clinical applications." Biochimica et Biophysica Acta. [2] Cooper, A. J., et al. (2011). "The importance of sulfhydryl groups in mitochondrial function." Journal of Bioenergetics and Biomembranes. [3] Koppaka, V., et al. (2012). "Aldehyde dehydrogenase inhibitors: a comprehensive review." Pharmacological Reviews. [4] Lu, J., & Holmgren, A. (2007). "Thioredoxin reductase as a target for anticancer drugs." Free Radical Biology and Medicine. [5] Valko, M., et al. (2005). "Metals, toxicity and oxidative stress." Current Medicinal Chemistry. [6] Conte, M. L., & Carroll, K. S. (2013). "The chemistry of thiol oxidation and detection." ACS Chemical Biology.
Covalent modification, oxidation, or metal-binding of the active-site cysteine thiol group, leading to enzyme inactivation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfhydryl-containing enzyme.